Magellan Health announced that it will be collaborating with Click Therapeutics to obtain Food and Drug Administration (FDA) clearance for therapeutic apps. Through this collaboration, Magellan seeks to extend its efforts in providing broad-based, digital, and data-driven programs for primary care and specialty care provider organizations.

Together, the two organizations will take advantage of each other's resources in order to create mobile apps for consumers living with conditions such as addiction disorder, insomnia, depression, and anxiety. They will then apply for FDA clearance for these apps, citing valid scientific evidence for the safety and efficacy of such . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Tech Updates

Submit a Bulletin
  • This field is for validation purposes and should be left unchanged.
  • Max. file size: 98 MB.